Patients in the Pompe Registry who switched from alglucosidase alfa to avalglucosidase alfa: Real-world experience

被引：0
|
作者：
Schoser, B. [1 ]
Abbott, M. [2 ]
Toscano, A. [3 ]
Foster, M. [4 ]
Periquet, M. [5 ]
Sparks, S. [4 ]
Kishnani, P. [6 ]
机构：
[1] LMU Klinikum Munchen, Dept Neurol, Friedrich Baur Inst, Munich, Germany
[2] Baystate Hlth, Springfield, MA USA
[3] Univ Messina, Dept Clin & Expt Med, Reference Ctr Rare Neuromuscular Disorders, Messina, Italy
[4] Sanofi, Cambridge, MA USA
[5] Sanofi, Berlin, Germany
[6] Duke Univ, Med Ctr, Durham, NC USA
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2023年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPO-394
引用
收藏
页码：572 / 573
页数：2
相关论文
共 50 条
  • [1] Patients in the Pompe registry who switched from alglucosidase alfa to avalglucosidase alfa: Real-world experience
    Schoser, B.
    Toscano, A.
    Foster, M.
    Periquet, M.
    Sparks, S.
    Kishnani, P.
    [J]. NEUROMUSCULAR DISORDERS, 2023, 33 : S152 - S152
  • [2] Real-world experience of switching treatments from alglucosidase alfa to avalglucosidase alfa for patients enrolled in the Pompe Registry
    Kishnani, Priya S.
    Abbott, Mary-Alice
    Toscano, Antonio
    Foster, Meredith C.
    Periquet, Magali
    Sparks, Susan
    Schoser, Benedikt
    [J]. MOLECULAR GENETICS AND METABOLISM, 2024, 141 (02)
  • [3] Real-world outcomes from a series of patients with late onset Pompe disease who switched from alglucosidase alfa to avalglucosidase alfa
    Carter, Chris
    Boggs, Tracy
    Case, Laura E.
    Kishnani, Priya
    [J]. FRONTIERS IN GENETICS, 2024, 15
  • [4] Characteristics of patients who have switched from alglucosidase alfa to avalglucosidase alfa: Baseline data from the Pompe Registry
    Schoser, Benedikt
    Abbott, Mary-Alice
    Toscano, Antonio
    Foster, Meredith C.
    Periquet, Magali
    Kishnani, Priya
    [J]. MOLECULAR GENETICS AND METABOLISM, 2023, 138 (02) : 118 - 118
  • [5] COMET: Safety of avalglucosidase alfa in patients with late-onset Pompe disease who switched treatment from alglucosidase alfa
    Diaz-Manera, J.
    Kishnani, P.
    Ladha, S.
    Miossec, P.
    Armstrong, N.
    Thibault, N.
    Periquet, M.
    Tammireddy, S.
    Dimachkie, M.
    Schoser, B.
    [J]. NEUROMUSCULAR DISORDERS, 2023, 33 : S152 - S152
  • [6] Miglustat does not enhance alglucosidase alfa or avalglucosidase alfa efficacy in Pompe mice
    Anding, Allyson
    Baranowski, Kaitlyn
    Brezzani, Alexander
    Dufault, Michael R.
    Keefe, Kelly
    Koellner, Tanya
    Zhang, Mindy
    Ziegler, Robin
    Sardi, S. Pablo
    Hunter, Bridge
    George, Kelly
    [J]. MOLECULAR GENETICS AND METABOLISM, 2021, 132 (02) : S15 - S15
  • [7] Avalglucosidase alfa in infantile-onset Pompe disease: A snapshot of real-world experience in Italy
    Fiumara, Agata
    Sapuppo, Annamaria
    Gasperini, Serena
    Crescitelli, Viola
    Sacchini, Michele
    Procopio, Elena
    Gragnaniello, Vincenza
    Burlina, Alberto
    [J]. MOLECULAR GENETICS AND METABOLISM REPORTS, 2024, 40
  • [8] Avalglucosidase alfa in patients with infantile-onset Pompe disease (IOPD): The Italian real world experience
    Sapuppo, Annamaria
    Gasperini, Serena
    Sacchini, Michele
    Procopio, Elena
    Gragnaniello, Vincenza
    Burlina, Alberto
    Fiumara, Agata
    [J]. MOLECULAR GENETICS AND METABOLISM, 2023, 138 (02) : 116 - 116
  • [9] Mini-COMET: Individual-level treatment responses in infantile-onset Pompe disease participants receiving avalglucosidase alfa or alglucosidase alfa who previously received alglucosidase alfa
    Kishnani, Priya
    Broomfield, Alexander
    Davison, James
    Labarthe, Francois
    Brassier, Anais
    Hahn, Si Houn
    Kumada, Satoko
    Ohki, Hirotaka
    Pichard, Samia
    Haack, Kristina An
    Johnson, Judith
    Meng, Xianzhang
    Chien, Yin-Hsiu
    Kronn, David
    [J]. MOLECULAR GENETICS AND METABOLISM, 2021, 132 : S75 - S76
  • [10] SWITCHING THERAPY FROM ALGLUCOSIDASE ALFA TO AVALGLUCOSIDASE ALFA IN PATIENTS WITH LATE ONSET POMPE DISEASE (LOPD): LONGITUDINAL ASSESSMENT OF RESPIRATORY FUNCTION FROM THE COMET TRIAL
    Berger, K., I
    Msihid, J.
    Periquet, M.
    Riou-Franca, L.
    Thibault, N.
    An, Haack K.
    Pollissard, L.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S28 - S28
12345